Hubei Qisheng Pharmaceutical Technology Co., Ltd., established in 2019 with a registered capital of 20 million RMB, covers an area of 64 acres and is equipped with 300 sets of reaction equipment. Located in the Yuekou Industrial Park of Tianmen City, Hubei Province, by the Han River, it is a high-tech enterprise dedicated to the manufacturing of advanced pharmaceutical active ingredients. As one of the major domestic suppliers of terbinafine hydrochloride intermediates, the company primarily engages in the production and sales of pharmaceutical intermediates. Its current large-scale production includes terbinafine hydrochloride chloride, adamantane, naphthalene, methylamine, as well as an annual purification capacity of 460 tons of d-alpha tocopherol, 200 tons of super lanolin, 10 tons of carnosic acid, 100 tons of fish oil, and 90 tons of natural linalyl acetate.

In its future development, the company will adhere to the operational philosophy of energy conservation, environmental protection, safety, technological innovation, and sustainable development. It will strengthen mechanisms for win-win cooperation, aiming for innovative transformation and leapfrog development. Leveraging its profound expertise in pharmaceutical chemicals, the company will extensively pursue technological innovation and R&D, continuously improve product quality, enhance production efficiency, and strive to maintain leading advantages in production technology and product quality within the industry.